Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma

The optimal duration of immune checkpoint blockade (ICB) therapy is not well established. Active residual disease is considered prohibitive for treatment discontinuation and its detection by diagnostic CT imag...

Source: Cancer Imaging - February 5, 2022 Category: Radiology Authors: Justin Ferdinandus, Anne Zaremba, Lisa Zimmer, Lale Umutlu, Robert Seifert, Francesco Barbato, Selma Ugurel, Eleftheria Chorti, Viktor Gr ünwald, Ken Herrmann, Dirk Schadendorf, Wolfgang Peter Fendler and Elisabeth Livingstone Tags: Research article Source Type: research